MedTrace Logo

Safety Analysis of Chronic Intake of a β-alanine Supplement

NCT05334121 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-07-26

No results posted yet for this study

Summary

Single-center, double-blind, placebo-controlled clinical trial with two arms (product and placebo) to analyze the safety of beta-alanine consumption in active people.

Conditions

  • Product Safety

Interventions

DIETARY_SUPPLEMENT

Beta-alanine

The product will be consumed every day for 4 weeks. Four intakes of 3g each, separated by three hours each, will be carried out.

OTHER

Control product consumption

Product with identical characteristics to the experimental product. The product will be consumed every day for 4 weeks. Four intakes of 3g each, separated by three hours each, will be carried out.

Sponsors & Collaborators

  • Universidad Católica San Antonio de Murcia

    lead OTHER

Principal Investigators

  • Fco Javier López Román · Catholic University of Murcia

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-21
Primary Completion
2022-04-25
Completion
2022-05-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05334121 on ClinicalTrials.gov